Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Collegium PharmaceuticalKadmonImmunoGenEagle PharmaceuticalsAkero Therapeutics
SymbolNASDAQ:COLLNYSE:KDMNNASDAQ:IMGNNASDAQ:EGRXNASDAQ:AKRO
Price Information
Current Price$19.85$4.31$4.59$49.54$24.37
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.82.11.41.01.4
Analysis Score3.43.53.41.33.5
Community Score2.52.62.42.92.3
Dividend Score0.00.00.00.00.0
Ownership Score0.04.01.01.01.0
Earnings & Valuation Score3.10.60.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$32.50$12.00$10.50$52.50$32.33
% Upside from Price Target63.77% upside178.42% upside128.76% upside5.97% upside32.68% upside
Trade Information
Market Cap$720.71 million$689.71 million$824.94 million$677.96 million$653.19 million
Beta1.071.472.310.99N/A
Average Volume473,1943,310,4982,389,962158,911173,274
Sales & Book Value
Annual Revenue$296.70 million$5.09 million$82.27 million$195.89 millionN/A
Price / Sales2.30135.519.733.46N/A
CashflowN/AN/AN/A$1.80 per shareN/A
Price / CashN/AN/AN/A27.48N/A
Book Value$2.61 per share$0.95 per share($0.51) per share$13.11 per share$4.51 per share
Price / Book7.604.54-9.003.78N/A
Profitability
Net Income$-22,720,000.00$-61,370,000.00$-104,130,000.00$14.31 million$-43,760,000.00
EPS($0.68)($0.74)($0.70)$1.38($2.90)
Trailing P/E RatioN/AN/AN/A291.43N/A
Forward P/E Ratio7.6913.06N/A107.70N/A
P/E Growth$0.66N/AN/AN/AN/A
Net Margins-4.21%-813.33%-102.87%1.29%N/A
Return on Equity (ROE)-12.62%-142.79%N/A8.11%-36.61%
Return on Assets (ROA)-3.25%-66.34%-33.27%5.07%-34.76%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.77%0.20%N/A0.17%N/A
Current Ratio0.92%6.42%3.17%1.89%15.23%
Quick Ratio0.85%6.40%3.17%1.83%15.23%
Ownership Information
Institutional Ownership PercentageN/A85.64%78.80%96.02%76.82%
Insider Ownership Percentage8.08%2.95%3.77%31.70%N/A
Miscellaneous
Employees266116296968
Shares Outstanding34.34 million160.03 million174.41 million13.69 million28.67 million
Next Earnings Date8/5/2020 (Estimated)8/3/2020 (Estimated)8/7/2020 (Estimated)8/13/2020 (Estimated)8/10/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.